Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823

Measuring inconsistency in meta-analyses

Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781

Methodological index for non‐randomized studies ( MINORS ): development and validation of a new instrument

Slim, K., Nini, E., Forestier, D., Kwiatkowski, F., Panis, Y., & Chipponi, J. (2003) · ANZ Journal of Surgery · doi:10.1046/j.1445-2197.2003.02748.x · Cited by 7,603

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836

Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity

Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664

The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update

Assi, R. A., Abdulbaqi, I. M., & Chan, S. Y. (2021) · Pharmaceuticals · doi:10.3390/ph14030215 · Cited by 33

Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management

Geerts, A. M., & Lefere, S. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0373 · Cited by 33

Current challenges and future perspectives in treating patients with NAFLD-related cirrhosis

Mallet, M., Silaghi, C. A., Sultanik, P., Conti, F., Rudler, M., Ratziu, V., Thabut, D., & Pais, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000456 · Cited by 31

Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review

Hashem, A. M., Khalouf, A., & Acosta, A. J. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1731704 · Cited by 31

Bariatric Surgery is Effective and Safe for Obese Patients with Compensated Cirrhosis: A Systematic Review and Meta‐Analysis

Bai, J., Jia, Z., Chen, Y., Li, Y., Zheng, S., & Duan, Z. (2022) · World Journal of Surgery · doi:10.1007/s00268-021-06382-z · Cited by 30

Impacts of bariatric surgery on adverse liver outcomes: a systematic review and meta-analysis

Wang, G., Huang, Y., Yang, H., Lin, H., Zhou, S., & Qian, J. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.12.025 · Cited by 29

Towards precision medicine in bariatric surgery prescription

Pereira, S. S., Guimarães, M., & Monteiro, M. P. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09801-9 · Cited by 34

Bariatric Surgery and Longitudinal Cancer Risk

Lim, P., Stucky, C., Wasif, N., Etzioni, D. A., Harold, K. L., Madura, J. A., & Fong, Z. V. (2024) · JAMA Surgery · doi:10.1001/jamasurg.2023.5809 · Cited by 30

Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management

Rinella, M. E., & Sookoian, S. C. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01187-8 · Cited by 31

Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan

Tuccinardi, D., Masi, D., Watanabe, M., Zanghi Buffi, V., De Domenico, F., Berti, S., Cipriani, V., Manco, M., Manfrini, S., & Pagotto, U. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02700-7 · Cited by 29

Noninvasive stratification of nonalcoholic fatty liver disease by whole transcriptome cell-free mRNA characterization

Chalasani, N., Toden, S., Sninsky, J. J., Rava, R. P., Braun, J. V., Gawrieh, S., Zhuang, J., Nerenberg, M. I., Quake, S. R., & Maddala, T. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00397.2020 · Cited by 26

Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD)

Grattagliano, I., Ciaula, A. D., Baj, J., Molina‐Molina, E., Shanmugam, H., Garruti, G., Wang, D. Q. ‐., & Portincasa, P. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1433-4_12 · Cited by 28

Bariatric surgery for metabolic dysfunction-associated steatotic liver disease (MASLD): Current knowledge of mechanisms

Liu, H., Lefere, S., Guillot, A., Zheng, M., & Tacke, F. (2025) · Hepatology · doi:10.1097/hep.0000000000001417 · Cited by 30

A Specifically Tailored Multistrain Probiotic and Micronutrient Mixture Affects Nonalcoholic Fatty Liver Disease—Related Markers in Patients with Obesity after Mini Gastric Bypass Surgery

Crommen, S., Rheinwalt, K. P., Plamper, A., Simon, M., Rösler, D., Fimmers, R., Egert, S., & Metzner, C. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab392 · Cited by 27

Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study

Adejumo, A., Cholankeril, G. T., Iqbal, U., Yoo, E. R., Boursiquot, B. C., Concepcion, W., Kim, D., & Ahmed, A. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05759-4 · Cited by 25

PIM1 alleviated liver oxidative stress and NAFLD by regulating the NRF2/HO-1/NQO1 pathway

Yang, K., Yu, X., Guo, Z., Fang, Z., Zhang, H., Zhang, W., Liu, C., Ji, Y., Dong, Z., Gu, Q., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122714 · Cited by 24

Development and Validation of a Predictive Model of Success in Bariatric Surgery

Blume, C. A., Brust-Renck, P. G., ROCHA, M. K., Leivas, G., Neyeloff, J. L., Anzanello, M. J., Fogliatto, F. S., Bahia, L., Teló, G. H., & Schaan, B. D. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05103-0 · Cited by 27

Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease

Brown, E. E., Hydes, T., Hamid, A., & Cuthbertson, D. J. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.07.013 · Cited by 25

Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease

Ivashkin, V. T., Drapkina, O. M., Maevskaya, M. V., Raikhelson, K. L., Okovityi, S. V., Жаркова, М. С., Grechishnikova, V. R., Abdulganieva, D. I., Alekseenko, S. A., Ardatskaya, M. D., et al. (2025) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2025-35-1-94-152 · Cited by 29

Clinical Impact of Antecedent Bariatric Surgery on Liver Transplant Outcomes: A Retrospective Matched Case-control Study

Serrano, O. K., Peterson, K. J., Vock, D. M., Berglund, D. M., Kandaswamy, R., Lake, J. R., Pruett, T. L., & Chinnakotla, S. (2020) · Transplantation · doi:10.1097/tp.0000000000003378 · Cited by 23

Regression of Hepatic Fibrosis After Endoscopic Gastric Plication in Nonalcoholic Fatty Liver Disease

Jirapinyo, P., Zucker, S. D., & Thompson, C. C. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002087 · Cited by 23

Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Differently Affect Oxidative Damage Markers and their Correlations with Body Parameters

Venâncio, F. A., Almeida, L. A., Zovico, P. V. C., Baraúna, V. G., Miguel, G. P. S., Pedrosa, R. G., & Haraguchi, F. K. (2021) · Obesity Surgery · doi:10.1007/s11695-020-05179-8 · Cited by 22

Improvement of non‐alcoholic fatty liver disease after laparoscopic sleeve gastrectomy in Japanese obese patients

Endo, Y., Ohta, M., Tada, K., Nakanuma, H., Saga, K., Masuda, T., Hirashita, T., Iwashita, Y., Ozeki, Y., Masaki, T., et al. (2019) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12234 · Cited by 21

A look to the future in non‐alcoholic fatty liver disease: Are glucagon‐like peptide‐1 analogues or sodium‐glucose co‐transporter‐2 inhibitors the answer?

Vincent, R. K., Williams, D. M., & Evans, M. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14196 · Cited by 21

Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus

Padda, J., Khalid, K., Khedr, A., Tasnim, F., Al-Ewaidat, O. A., Cooper, A. C., & Jean-Charles, G. (2021) · Cureus · doi:10.7759/cureus.17321 · Cited by 24

Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review

Schattenberg, J. M., Anstee, Q. M., Caussy, C., Bugianesi, E., & Popovic, B. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1974295 · Cited by 21

Very low energy diets prior to bariatric surgery may reduce postoperative morbidity: a systematic review and meta-analysis of randomized controlled trials

McKechnie, T., Lee, Y., Dionne, J. C., Doumouras, A. G., Parpia, S., Bhandari, M., & Eskicioglu, C. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1211575 · Cited by 22

Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure

Inciardi, R. M., Mantovani, A., & Targher, G. (2023) · Current Heart Failure Reports · doi:10.1007/s11897-023-00613-1 · Cited by 25

Obesity and breast cancer: Preventive and therapeutic possibilities for bariatric surgery

Crafts, T. D., Tonneson, J. E., Wolfe, B. M., & Stroud, A. (2022) · Obesity · doi:10.1002/oby.23369 · Cited by 23

Post-hepatectomy liver failure: A timeline centered review

Bekheit, M., Grundy, L., Salih, A. K. A., Bucur, P. O., Vibert, É., & Ghazanfar, M. A. (2023) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2023.03.001 · Cited by 22

Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention

Shao, Y., Chen, S., Liu, H., & Liu, J. (2023) · Nutrition & Metabolism · doi:10.1186/s12986-023-00748-x · Cited by 20

ASMBS Position Statement on the Impact of Metabolic and Bariatric Surgery on Nonalcoholic Steatohepatitis

Mazzini, G. S., Augustin, T., Noria, S. F., Romero‐Marrero, C., Li, N., Hameed, B., Eisenberg, D., Azagury, D. E., & Ikramuddin, S. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.11.015 · Cited by 20

Metabolic dysfunction-associated steatotic liver disease and heart failure with preserved ejection fraction: A state-of-the-art review

Brar, A. S., Khanna, T., Sohal, A., Hatwal, J., Sharma, V., Singh, C. M., Batta, A., Chandra, P., & Mohan, B. (2026) · World Journal of Cardiology · doi:10.4330/wjc.v18.i1.111954 · Cited by 25

Gastric Bypass Increases Circulating Bile Acids and Activates Hepatic Farnesoid X Receptor (FXR) but Requires Intact Peroxisome Proliferator Activator Receptor Alpha (PPARα) Signaling to Significantly Reduce Liver Fat Content

Mazzini, G. S., Khoraki, J., Browning, M. G., Wu, J., Zhou, H., Price, E. T., Wolfe, L. G., Mangino, M. J., & Campos, G. M. (2021) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-04908-3 · Cited by 20

Management of NAFLD patients with advanced fibrosis

Maya‐Miles, D., Ampuero, J., Gallego‐Durán, R., D’Ingianna, P., & Romero‐Gómez, M. (2021) · Liver International · doi:10.1111/liv.14847 · Cited by 19

Therapeutic Targets and Approaches to Manage Inflammation of NAFLD

Geng, W., Liao, W., Cao, X., & Yang, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13020393 · Cited by 20

Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management

Adinolfi, L. E., Marrone, A., Rinaldi, L., Nevola, R., Izzi, A., & Sasso, F. C. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001281 · Cited by 18

Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma

Cernea, S., & Onișor, D. M. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i2.286 · Cited by 18

Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies

Agyapong, G., Dashti, F., & Banini, B. A. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15012 · Cited by 18

Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients

Pérez-Rubio, Á., Soluyanova, P., Moro, E., Quintás‐Cardama, A., Rienda, I., Gómez, M. D. P., Painel, A., Vizuete, J., Pérez‐Rojas, J., Castell, J. V., et al. (2023) · Nutrients · doi:10.3390/nu15143187 · Cited by 17

New drug therapies for metabolic dysfunction-associated steatohepatitis

Chiang, J. Y. L. (2025) · Liver Research · doi:10.1016/j.livres.2025.01.001 · Cited by 18

Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery

Martínez‐Montoro, J. I., Kuchay, M. S., Román, A. B., Martínez‐Sánchez, M. A., Frutos, M. D., Fernández‐García, J. C., & Ramos‐Molina, B. (2021) · Obesity Reviews · doi:10.1111/obr.13367 · Cited by 16

Nonalcoholic fatty liver disease and diabetes

Bellini, M. I., Urciuoli, I., Gaudio, G. D., Polti, G., Iannetti, G., Gangitano, E., Lori, E., Lubrano, C., Cantisani, V., Sorrenti, S., et al. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i9.668 · Cited by 18

Meta‐analysis: Impact of intragastric balloon therapy on NAFLD‐related parameters in patients with obesity

Aoko, O., Maharaj, T., Boland, F., Cheriyan, D. G., & Ryan, J. D. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17805 · Cited by 16

Bariatric surgery for treatment of morbid obesity in adults

Park, K. B., & Jun, K. (2024) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2024.219 · Cited by 17

Metabolic endoscopy: Today’s science—tomorrow’s treatment

Hadefi, A., Arvanitakis, M., Huberty, V., & Deviere, J. M. E. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620926837 · Cited by 16

Preparing for the NASH epidemic: A call to action

Kanwal, F., Shubrook, J. H., Younossi, Z. M., Natarajan, Y., Bugianesi, E., Rinella, M. E., Harrison, S. A., Mantzoros, C. S., Pfotenhauer, K. M., Klein, S., et al. (2021) · Obesity · doi:10.1002/oby.23250 · Cited by 18

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease

van Dijk, A., Schattenberg, J. M., Holleboom, A. G., & Tushuizen, M. E. (2021) · United European Gastroenterology Journal · doi:10.1002/ueg2.12150 · Cited by 16

Prevalence of Elevated Liver Stiffness Among Potential Candidates for Bariatric Surgery in the United States

Ciardullo, S., Pizzi, M., Pizzi, P., Oltolini, A., Muraca, E., & Perseghin, G. (2022) · Obesity Surgery · doi:10.1007/s11695-021-05885-x · Cited by 15

Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes

Tsamos, G., Vasdeki, D., Koufakis, T., Michou, V., Makedou, K., & Tzimagiorgis, G. (2023) · Metabolites · doi:10.3390/metabo13040517 · Cited by 16

Comparison of Liver Recovery After Sleeve Gastrectomy and Roux-en-Y-Gastric Bypass

Schmitz, S. M., Kroh, A., Koch, A. H., Brozat, J. F., Stier, C. K., Neumann, U. P., Ulmer, T. F., & Alizai, P. H. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05390-1 · Cited by 15

Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases

Mendoza, Y. P., Becchetti, C., Watt, K. D. S., & Berzigotti, A. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1731705 · Cited by 16

Approach to the Patient With Nonalcoholic Fatty Liver Disease

Belfort‐DeAguiar, R., Lomonaco, R., & Cusi, K. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac624 · Cited by 16

Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery

Yang, A., Nguyen, M., Ju, I. E., Brancatisano, A., Ryan, B., & van der Poorten, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-93294-6 · Cited by 15

S2k-Leitlinie Klinische Ernährung in der Hepatologie

Plauth, M., Bechmann, L. P., Grajecki, D., Gundling, F., Kramer, L., Kremer, A. E., Rau, M., Schneider, A., Tacke, F., & van Thiel, I. (2024) · Aktuelle Ernährungsmedizin · doi:10.1055/a-2338-1144 · Cited by 14

“Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”

Hanna, D. J., Jamieson, S. T., Lee, C. S., Pluskota, C. A., Bressler, N., Benotti, P. N., Khurana, S., Rolston, D. D. K., & Still, C. D. (2021) · Obesity Science & Practice · doi:10.1002/osp4.509 · Cited by 14

A history of bariatric surgery before surgery for colorectal cancer may improve short-term postoperative outcomes: Analysis of the national inpatient sample 2015–2019

McKechnie, T., Lee, Y., Hong, D., Dionne, J. C., Doumouras, A. G., Parpia, S., Bhandari, M., & Eskicioglu, C. (2023) · Surgery · doi:10.1016/j.surg.2023.08.011 · Cited by 14

Practical Approaches to Managing Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Bril, F., Berg, G. A., Barchuk, M., & Nogueira, J. P. (2025) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2025.14.1.5 · Cited by 15

Mitochondria at the Crossroads: Linking the Mediterranean Diet to Metabolic Health and Non-Pharmacological Approaches to NAFLD

Mercurio, G., Giacco, A., Scopigno, N., Vigliotti, M., Goglia, F., Cioffi, F., & Silvestri, E. (2025) · Nutrients · doi:10.3390/nu17071214 · Cited by 16

Caspase-Cleaved Keratin 18 Measurements Identified Ongoing Liver Injury after Bariatric Surgery

Hempel, F., Roderfeld, M., Müntnich, L. J., Albrecht, J., Oruc, Z., Arneth, B. M., Karrasch, T., Pons‐Kühnemann, J., Padberg, W. M., Renz, H. E., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061233 · Cited by 14

Obesity, Cancer, and Risk Reduction with Bariatric Surgery

Malík, P., Doumouras, A. G., Malhan, R., Lee, Y., Boudreau, V., Barlow, K., Karpinski, M., & Anvari, M. (2021) · Surgical Clinics of North America · doi:10.1016/j.suc.2020.12.003 · Cited by 15

Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy

Friesen, C. S., Hosey, C. M., Chan, S. S., Csanaky, I. L., Wagner, J. B., Sweeney, B. R., Friesen, A., Fraser, J. D., & Shakhnovich, V. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.663351 · Cited by 14

Sleeve Gastrectomy Is Associated with a Greater Reduction in Plasma Liver Enzymes Than Bypass Surgeries—A Registry-Based Two-Year Follow-Up Analysis

Azulai, S., Grinbaum, R., Beglaibter, N., Eldar, S. M., Rubin, M., Ben-Haroush Schyr, R., Romano-Zelekha, O., & Ben-Zvi, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051144 · Cited by 13

Bariatric Surgery Outcomes in Patients with Previous Organ Transplant: Scoping Review and Analysis of the MBSAQIP

Verhoeff, K. K., Dang, J. T., Modasi, A., Switzer, N. J., Birch, D. W., & Karmali, S. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05042-w · Cited by 13

Therapeutic developments in metabolic dysfunction-associated fatty liver disease

Shi, Y., & Fan, J. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002091 · Cited by 14

Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis

Bocca, C., Protopapa, F., Foglia, B., Maggiora, M., Cannito, S., Parola, M., & Novo, E. (2022) · Antioxidants · doi:10.3390/antiox11071278 · Cited by 14

Potential Therapeutic Targets in Obesity, Sleep Apnea, Diabetes, and Fatty Liver Disease

Gu, C., Bernstein, N., Mittal, N., Kurnool, S., Schwartz, H. R., Loomba, R. S., & Malhotra, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082231 · Cited by 14

Combined non-alcoholic fatty liver disease and type 2 diabetes in severely obese patients—medium term effects of sleeve gastrectomy versus Roux-en-Y-gastric bypass on disease markers

Billmann, F. G., Shishtawi, S. E., Bruckner, T., ElSheikh, M., Müller-Stich, B. P., & Billeter, A. T. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-21-71 · Cited by 12

Obesity and Nonalcoholic Fatty Liver Disease

Chaney, A. J. (2021) · Nursing Clinics of North America · doi:10.1016/j.cnur.2021.07.009 · Cited by 14

Sleeve gastrectomy causes weight‐loss independent improvements in hepatic steatosis

McGlone, E. R., Siebert, M., Dore, M. H., Hope, D. C. D., Davies, I., Owen, B. M., Khoo, B. C. E., Goldin, R. D., Carling, D., Bloom, S. R., et al. (2023) · Liver International · doi:10.1111/liv.15614 · Cited by 12

The role of bariatric surgery in the management of nonalcoholic steatohepatitis

Seymour, K. A., & Abdelmalek, M. F. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000721 · Cited by 13

Weight loss, insulin resistance, and study design confound results in a meta-analysis of animal models of fatty liver

Hunter, H., de Gracia Hahn, D., Duret, A., Im, Y. R., Cheah, Q., Dong, J., Fairey, M., Hjalmarsson, C., Li, A., Lim, H. K., et al. (2020) · eLife · doi:10.7554/elife.56573 · Cited by 12

Comparative effectiveness of tirzepatide versus bariatric metabolic surgery in adults with metabolic-associated steatotic liver disease and obesity: a multi-institutional propensity score-matched study

Wu, J., Lin, Y., Hsu, W., Liu, T., Tsai, Y., Huang, P., Chuang, M., Yu, T., & Lai, C. (2025) · Hepatology International · doi:10.1007/s12072-025-10857-9 · Cited by 12

Breakthrough in the Treatment of Metabolic Associated Steatotic Liver Disease: Is it all over?

Petroni, M. L., Perazza, F., & Marchesini, G. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.04.021 · Cited by 13

An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents

Rubin, V. R., Bojanić, K., Smolić, M., Rubin, J., Tabll, A. A., & Smolić, R. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00040 · Cited by 12

Interventions for non-alcoholic liver disease: a gut microbial metabolites perspective

Guo, J., Shi, C., Zhang, Q., Deng, W., Zhang, L., Chen, Q., Zhang, D., & Gong, Z. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221138676 · Cited by 14

The Effect of Laparoscopic Sleeve Gastrectomy on the Course of Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients during One Year of Follow Up

Głuszyńska, P., Łukaszewicz, A., Diemieszczyk, I., Chilmończyk, J., Reszeć, J., Citko, A., Szczerbiński, Ł., Kretowski, A. J., & Hady, H. R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124122 · Cited by 12

Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease—The Union of Two Culprits

Ali, S. E., & Nguyen, M. H. (2021) · Life · doi:10.3390/life11020119 · Cited by 12

Bariatric surgery and non-alcoholic fatty liver disease

Julià, H., Benaiges, D., & Pedro‐Botet, J. (2022) · Medicina Clínica · doi:10.1016/j.medcli.2021.12.003 · Cited by 11

Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?

Bhandari, P., Sapra, A., Ajmeri, M. S., Albers, C. E., & Sapra, D. (2022) · Cureus · doi:10.7759/cureus.23806 · Cited by 11

The Effect of Roux-en-Y Gastric Bypass on Non-Alcoholic Fatty Liver Disease Fibrosis Assessed by FIB-4 and NFS Scores—An 11.6-Year Follow-Up Study

Sandvik, E. C. S., Aasarød, K. M., Johnsen, G., Hoff, D. A. L., Kulseng, B. E., Hyldmo, Å. A., Græslie, H., Nymo, S., Sandvik, J., & Fossmark, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164910 · Cited by 11

Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver

Leiva, E. G., & Bril, F. (2020) · Current Hypertension Reviews · doi:10.2174/1573402116999201209203534 · Cited by 11

Expert opinion on the preoperative medical optimization of adults with diabetes undergoing metabolic surgery

Bhattacharya, S., Kalra, S., Kapoor, N., Singla, R., Dutta, D., Aggarwal, S., Khandelwal, D., Surana, V., Dhingra, A., Kantroo, V., et al. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i10.1587 · Cited by 12

Diagnosis and Management of MASLD: An Metabolic Perspective of a Multisystem Disease

Ganakumar, V., Halebidu, T., Goroshi, M., & Ghatnatti, V. (2024) · International journal of clinical metabolism and diabetes. · doi:10.1177/30502071231220779 · Cited by 10

Weight Loss After Sleeve Gastrectomy According to Metabolic Dysfunction-Associated Steatotic Liver Disease Stage in Patients with Obesity: A Liver Biopsy-Based Prospective Study

Martínez‐Montoro, J. I., Arranz‐Salas, I., Gutiérrez‐Repiso, C., García, A. M. S., Ocaña-Wilhelmi, L., Pinazo-Bandera, J. M., Fernández‐García, D., Muñoz‐Garach, A., Morales-García, D. J., García‐Cortés, M., et al. (2024) · Nutrients · doi:10.3390/nu16223857 · Cited by 10

Preventing the progression of cirrhosis to decompensation and death

Villanueva, C., Tripathi, D., & Bosch, J. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-01031-x · Cited by 13

Clinical Assessment of People With Obesity: Focus on Adiposity-Related Multimorbidity

Bianchettin, R. G., Gawey, B. J., Acosta, A. J., Borlaug, B. A., Caples, S. M., Collazo–Clavell, M. L., Clark, M. M., Lara-Breitinger, K. M., Lerman, A., Lerman, L. O., et al. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.02.021 · Cited by 13

The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis

Yeoh, A. J., Wong, R. J., & Singal, A. K. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.01.009 · Cited by 10

Mid-term Effects of Bariatric Surgery on Metabolic Dysfunction-Associated Fatty Liver Disease Remission and Predictive Factors: A Prospective Study with a Focus on Non-invasive Diagnosis

Navarro‐Masip, È., Petit, N. M., Zorzano-Martínez, M., Salinas‐Roca, B., Sánchez, E., López‐Cano, C., Herrerías, F., de la Fuente, M. C., Santamaría, M., León, J., et al. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07071-1 · Cited by 10

Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease

Martínez‐Montoro, J. I., Cornejo-Pareja, I. M., Gómez‐Pérez, A. M., & Tinahones, F. J. (2021) · Nutrients · doi:10.3390/nu13114077 · Cited by 11

Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals

Lim, W. H., Lin, S. Y., Ng, C. H., Tan, D. J. H., Xiao, J., Yong, J. N., Tay, P. W. L., Syn, N. L. X., Chin, Y. H., Chan, K. E., et al. (2022) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-21-520 · Cited by 10

Gastric banding-associated weight loss diminishes hepatic Tsukushi expression

Grander, C., Jaschke, N., Enrich, B., Grabherr, F., Mayr, L., Schwärzler, J., Effenberger, M., Adolph, T. E., & Tilg, H. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155114 · Cited by 10

Hepatic Meteorin-like and Krüppel-like Factor 3 are Associated with Weight Loss and Liver Injury

Grander, C., Grabherr, F., Enrich, B., Meyer, M., Mayr, L., Schwärzler, J., Pedrini, A., Effenberger, M., Adolph, T. E., & Tilg, H. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1537-8950 · Cited by 9

Reliability of Non-invasive Liver Fibrosis Assessment Tools Versus Biopsy in Pre- and Post-bariatric Surgery Patients with Non-alcoholic Fatty Liver Disease

Schwenger, K. J. P., Alali, M., Ghorbani, Y., Fischer, S. E., Jackson, T. D., Okrainec, A., & Allard, J. P. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06380-7 · Cited by 9

Impact of Nonalcoholic Fatty Liver Disease (NAFLD) on Weight Loss After Bariatric Surgery

Abu-Rumaileh, M. A., Haddad, R. A., Yosef, M., Esfandiari, N. H., Kraftson, A. T., Khairi, S., Lager, C. J., Bushman, J., Khalatbari, S., Tincopa, M. A., et al. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06865-z · Cited by 9

Acute liver failure after bariatric surgery

Önem, S., Cengiz, O., Dolu, S., Bilgen, A., & Akarsu, M. (2020) · Hepatology forum/Hepatology forum (Online) · doi:10.14744/hf.2020.2020.0016 · Cited by 9

Ockham’s razor and the metabolic syndrome

Pories, W. J., Jones, T. E., Houmard, J. A., DeMaria, E. J., & Dohm, G. L. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.04.004 · Cited by 9

Target Therapies for NASH/NAFLD: From the Molecular Aspect to the Pharmacological and Surgical Alternatives

Finotti, M., Romano, M., Auricchio, P., Scopelliti, M., Brizzolari, M., Grossi, U., Piccino, M., Benvenuti, S., Morana, G., Cillo, U., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060499 · Cited by 9

Bariatric endoscopic-surgical therapies for NAFLD. Should they be considered viable options among current treatments?

Juárez-Hernández, E., Velázquez-Alemán, A. P., Castro‐Narro, G., Uribe, M., & López-Méndez, I. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1026444 · Cited by 9

Prognostic factors in resolution of nonalcoholic fatty liver disease post bariatric surgery in adolescents

Bacha, F. F., Gupta, R., Jenkins, T. M., Brandt, M. L., Inge, T. H., Kleiner, D. E., & Xanthakos, S. A. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.11.004 · Cited by 8

Bariatric surgery improves nonalcoholic fatty liver disease: systematic review and meta-analysis

Zhou, H., Luo, P., Li, P., wang, G., Yi, X., Fu, Z., Sun, X., Cui, B., Zhu, L., & Zhu, S. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06011-1 · Cited by 79

Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis

Mummadi, R. R., Kasturi, K. S., Chennareddygari, S., & Sood, G. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.012 · Cited by 511

Bariatric surgery improves nonalcoholic fatty liver disease: A contemporary systematic review and meta-analysis

Fakhry, T. K., Mhaskar, R., Schwitalla, T., Muradova, E., Gonzalvo, J. P., & Murr, M. M. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.12.002 · Cited by 259

Long-term Effects of Bariatric Surgery in Patients with Non-alcoholic Fatty Liver Disease: A Literature Review and Meta-Analysis

Wells, M. M., Schneier, A., Ganjoo, N., Schiano, T. D., & Pinotti, R. (2016) · The American Journal of Gastroenterology · doi:10.14309/00000434-201610001-00850

Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology

Bower, G., Toma, T., Harling, L., Jiao, L. R., Efthimiou, E., Darzi, A. W., Athanasiou, T., & Ashrafian, H. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1691-x · Cited by 261